Activist 13D/13G Filings - Avalo Therapeutics Inc. (AVTX)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-05-13
12:38 pm
Purchase
13GAVALO THERAPEUTICS INC PAR
AVTX
Allostery Investments LP78,255
7.6%
78,255increase
(New Position)
View
2024-04-23
2:59 pm
Purchase
13GAVALO THERAPEUTICS INC PAR
AVTX
Emerald Bioventures LLC58,346
5.6%
58,346increase
(New Position)
View
2024-04-05
4:00 pm
Purchase
13GAVALO THERAPEUTICS INC PAR
AVTX
Deep Track Capital LP114,775
9.99%
114,775increase
(New Position)
View
2024-02-14
9:13 pm
Unchanged
13GAVALO THERAPEUTICS INC PAR
AVTX
Venrock Healthcare Capital Partners III L.P.0
0%
0
(Unchanged)
View
2024-02-14
4:51 pm
Sale
13GAVALO THERAPEUTICS INC PAR
AVTX
Nantahala Capital Management LLC42,100
4.9%
-612,574decrease
(-93.57%)
View
2024-02-14
4:36 pm
Purchase
13GAVALO THERAPEUTICS INC PAR
AVTX
GREAT POINT PARTNERS LLC2,085
0.26%
2,085increase
(New Position)
View
2024-02-14
10:02 am
Purchase
13GAVALO THERAPEUTICS INC PAR
AVTX
Point72 Asset Management L.P.2,500
0.3%
2,500increase
(New Position)
View
2023-06-29
08:22 am
Sale
13GAVALO THERAPEUTICS INC PAR
AVTX
Caissa Capital Management ltd.0
0%
-1,475,000decrease
(Position Closed)
View
2023-06-27
6:02 pm
Sale
13DAVALO THERAPEUTICS INC PAR
AVTX
ARMISTICE CAPITAL LLC623,220
4.99%
-4,159,483decrease
(-86.97%)
View
2023-04-19
4:38 pm
Purchase
13GAVALO THERAPEUTICS INC PAR
AVTX
Caissa Capital Management ltd.1,475,000
11.19%
81,329increase
(+5.84%)
View
2023-02-17
4:05 pm
Purchase
13GAVALO THERAPEUTICS INC PAR
AVTX
Venrock Healthcare Capital Partners III L.P.1,352,285
9.99%
1,352,285increase
(New Position)
View
2023-02-14
4:58 pm
Sale
13GAVALO THERAPEUTICS INC PAR
AVTX
Nantahala Capital Management LLC654,674
7%
-7,859,243decrease
(-92.31%)
View
2023-02-14
4:22 pm
Purchase
13GAVALO THERAPEUTICS INC PAR
AVTX
Point72 Asset Management L.P.500,737
5.3%
500,737increase
(New Position)
View
2023-02-14
4:09 pm
Purchase
13GAVALO THERAPEUTICS INC PAR
AVTX
Caissa Capital Management ltd.1,393,671
10.57%
413,113increase
(+42.13%)
View
2023-02-13
4:10 pm
Purchase
13GAVALO THERAPEUTICS INC PAR
AVTX
GREAT POINT PARTNERS LLC974,639
7.12%
974,639increase
(New Position)
View
2023-02-09
4:27 pm
Purchase
13DAVALO THERAPEUTICS INC PAR
AVTX
ARMISTICE CAPITAL LLC4,782,703
35.4%
450,333increase
(+10.39%)
View
2022-08-11
4:09 pm
Sale
13DAVALO THERAPEUTICS INC PAR
AVTX
ARMISTICE CAPITAL LLC4,332,370
44.4%
-47,656,072decrease
(-91.67%)
View
2022-08-08
07:23 am
Sale
13GAVALO THERAPEUTICS INC PAR
AVTX
Caissa Capital Management ltd.980,558
10.43%
-5,119,442decrease
(-83.93%)
View
2022-05-17
3:45 pm
Purchase
13GAVALO THERAPEUTICS INC PAR
AVTX
Caissa Capital Management ltd.6,100,000
5.41%
6,100,000increase
(New Position)
View
2022-03-15
5:16 pm
Purchase
13DAVALO THERAPEUTICS INC PAR
AVTX
ARMISTICE CAPITAL LLC51,988,442
44.5%
1,176,000increase
(+2.31%)
View
Goto 0, 1, 2, Next